ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,874Medicare Part D Prescriptions Filled, Including Refills

Rank: 233 out of 1844

$689K Total Retail Price of All Prescriptions

Rank: 156 out of 1844

567 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,677 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 439 191 S3 1 2
SIMVASTATIN 317 257 2 3
AMLODIPINE BESYLATE 276 220 3 6
LISINOPRIL 268 190 4 4
FUROSEMIDE 232 176 5 7
LEVOTHYROXINE SODIUM 222 147 6 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 205 142 7 20
METFORMIN HCL 194 122 8 8
OMEPRAZOLE 180 91 9 5
ATENOLOL 167 97 10 17
PRAVASTATIN SODIUM 159 133 11 10
METOPROLOL TARTRATE 156 95 12 11
ATORVASTATIN CALCIUM 150 119 13 12
GLIMEPIRIDE 139 100 14 35
CLOPIDOGREL 133 105 15 34
ZOLPIDEM TARTRATE 132 86 16 23
POTASSIUM CHLORIDE 130 98 17 16
ISOSORBIDE MONONITRATE ER 126 105 18 59
NEXIUM 107 62 19 31
OXYCODONE HCL-ACETAMINOPHEN 106 58 S2 20 83
HYDROCHLOROTHIAZIDE 106 58 20 9
PROAIR HFA 103 32 22 45
CITALOPRAM HBR 97 73 23 19
GABAPENTIN 94 36 24 15
DIGOXIN 91 67 25 67
METFORMIN HCL ER 90 80 26 46
SERTRALINE HCL 88 46 27 21
JANUVIA 88 52 27 77
WARFARIN SODIUM 87 70 29 13
CRESTOR 86 55 30 30
HYDRALAZINE HCL 85 73 31 120
PREDNISONE 80 64 32 40
PLAVIX 76 58 33 61
ALLOPURINOL 75 67 34 29
SPIRONOLACTONE 73 46 35 60
MORPHINE SULFATE ER 73 35 S2 35 107
MELOXICAM 72 49 37 28
METOPROLOL SUCCINATE 69 40 38 14
BACLOFEN 65 21 39 119
METOCLOPRAMIDE HCL 65 35 39 148
CYMBALTA 62 35 41 36
FENOFIBRATE 61 47 42 71
DILTIAZEM 24HR ER 60 60 43 146
LOSARTAN POTASSIUM 59 49 44 24
LANSOPRAZOLE 58 34 45 194
NAMENDA 56 50 46 33
MIRTAZAPINE 56 55 46 49
TRAMADOL HCL 55 27 48 18
SYNTHROID 53 43 49 55
PAROXETINE HCL 51 32 50 68
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 25 50 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.